Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antihistamines Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 10 mg
1.2.3 20 mg
1.2.4 30 mg
1.2.5 Others
1.3 Market by Application
1.3.1 Global Antihistamines Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Pharmacy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antihistamines Market Perspective (2018-2034)
2.2 Antihistamines Growth Trends by Region
2.2.1 Global Antihistamines Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Antihistamines Historic Market Size by Region (2018-2023)
2.2.3 Antihistamines Forecasted Market Size by Region (2024-2034)
2.3 Antihistamines Market Dynamics
2.3.1 Antihistamines Industry Trends
2.3.2 Antihistamines Market Drivers
2.3.3 Antihistamines Market Challenges
2.3.4 Antihistamines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antihistamines Players by Revenue
3.1.1 Global Top Antihistamines Players by Revenue (2018-2023)
3.1.2 Global Antihistamines Revenue Market Share by Players (2018-2023)
3.2 Global Antihistamines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antihistamines Revenue
3.4 Global Antihistamines Market Concentration Ratio
3.4.1 Global Antihistamines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antihistamines Revenue in 2024
3.5 Antihistamines Key Players Head office and Area Served
3.6 Key Players Antihistamines Product Solution and Service
3.7 Date of Enter into Antihistamines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antihistamines Breakdown Data by Type
4.1 Global Antihistamines Historic Market Size by Type (2018-2023)
4.2 Global Antihistamines Forecasted Market Size by Type (2024-2034)
5 Antihistamines Breakdown Data by Application
5.1 Global Antihistamines Historic Market Size by Application (2018-2023)
5.2 Global Antihistamines Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Antihistamines Market Size (2018-2034)
6.2 North America Antihistamines Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Antihistamines Market Size by Country (2018-2023)
6.4 North America Antihistamines Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antihistamines Market Size (2018-2034)
7.2 Europe Antihistamines Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Antihistamines Market Size by Country (2018-2023)
7.4 Europe Antihistamines Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antihistamines Market Size (2018-2034)
8.2 Asia-Pacific Antihistamines Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Antihistamines Market Size by Region (2018-2023)
8.4 Asia-Pacific Antihistamines Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antihistamines Market Size (2018-2034)
9.2 Latin America Antihistamines Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Antihistamines Market Size by Country (2018-2023)
9.4 Latin America Antihistamines Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antihistamines Market Size (2018-2034)
10.2 Middle East & Africa Antihistamines Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Antihistamines Market Size by Country (2018-2023)
10.4 Middle East & Africa Antihistamines Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck Antihistamines Introduction
11.1.4 Merck Revenue in Antihistamines Business (2018-2023)
11.1.5 Merck Recent Development
11.2 Viatris
11.2.1 Viatris Company Detail
11.2.2 Viatris Business Overview
11.2.3 Viatris Antihistamines Introduction
11.2.4 Viatris Revenue in Antihistamines Business (2018-2023)
11.2.5 Viatris Recent Development
11.3 Organon
11.3.1 Organon Company Detail
11.3.2 Organon Business Overview
11.3.3 Organon Antihistamines Introduction
11.3.4 Organon Revenue in Antihistamines Business (2018-2023)
11.3.5 Organon Recent Development
11.4 Sun Pharmaceutical Industries
11.4.1 Sun Pharmaceutical Industries Company Detail
11.4.2 Sun Pharmaceutical Industries Business Overview
11.4.3 Sun Pharmaceutical Industries Antihistamines Introduction
11.4.4 Sun Pharmaceutical Industries Revenue in Antihistamines Business (2018-2023)
11.4.5 Sun Pharmaceutical Industries Recent Development
11.5 Cardinal Health
11.5.1 Cardinal Health Company Detail
11.5.2 Cardinal Health Business Overview
11.5.3 Cardinal Health Antihistamines Introduction
11.5.4 Cardinal Health Revenue in Antihistamines Business (2018-2023)
11.5.5 Cardinal Health Recent Development
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Company Detail
11.6.2 Fresenius Kabi Business Overview
11.6.3 Fresenius Kabi Antihistamines Introduction
11.6.4 Fresenius Kabi Revenue in Antihistamines Business (2018-2023)
11.6.5 Fresenius Kabi Recent Development
11.7 Hikma Pharmaceutical
11.7.1 Hikma Pharmaceutical Company Detail
11.7.2 Hikma Pharmaceutical Business Overview
11.7.3 Hikma Pharmaceutical Antihistamines Introduction
11.7.4 Hikma Pharmaceutical Revenue in Antihistamines Business (2018-2023)
11.7.5 Hikma Pharmaceutical Recent Development
11.8 Meda Pharmaceuticals
11.8.1 Meda Pharmaceuticals Company Detail
11.8.2 Meda Pharmaceuticals Business Overview
11.8.3 Meda Pharmaceuticals Antihistamines Introduction
11.8.4 Meda Pharmaceuticals Revenue in Antihistamines Business (2018-2023)
11.8.5 Meda Pharmaceuticals Recent Development
11.9 Armas Pharmaceuticals
11.9.1 Armas Pharmaceuticals Company Detail
11.9.2 Armas Pharmaceuticals Business Overview
11.9.3 Armas Pharmaceuticals Antihistamines Introduction
11.9.4 Armas Pharmaceuticals Revenue in Antihistamines Business (2018-2023)
11.9.5 Armas Pharmaceuticals Recent Development
11.10 Strides Pharma
11.10.1 Strides Pharma Company Detail
11.10.2 Strides Pharma Business Overview
11.10.3 Strides Pharma Antihistamines Introduction
11.10.4 Strides Pharma Revenue in Antihistamines Business (2018-2023)
11.10.5 Strides Pharma Recent Development
11.11 Aurobindo Pharma
11.11.1 Aurobindo Pharma Company Detail
11.11.2 Aurobindo Pharma Business Overview
11.11.3 Aurobindo Pharma Antihistamines Introduction
11.11.4 Aurobindo Pharma Revenue in Antihistamines Business (2018-2023)
11.11.5 Aurobindo Pharma Recent Development
11.12 Perrigo Pharmaceuticals
11.12.1 Perrigo Pharmaceuticals Company Detail
11.12.2 Perrigo Pharmaceuticals Business Overview
11.12.3 Perrigo Pharmaceuticals Antihistamines Introduction
11.12.4 Perrigo Pharmaceuticals Revenue in Antihistamines Business (2018-2023)
11.12.5 Perrigo Pharmaceuticals Recent Development
11.13 Micro Labs USA
11.13.1 Micro Labs USA Company Detail
11.13.2 Micro Labs USA Business Overview
11.13.3 Micro Labs USA Antihistamines Introduction
11.13.4 Micro Labs USA Revenue in Antihistamines Business (2018-2023)
11.13.5 Micro Labs USA Recent Development
11.14 Sciegen Pharmaceutical
11.14.1 Sciegen Pharmaceutical Company Detail
11.14.2 Sciegen Pharmaceutical Business Overview
11.14.3 Sciegen Pharmaceutical Antihistamines Introduction
11.14.4 Sciegen Pharmaceutical Revenue in Antihistamines Business (2018-2023)
11.14.5 Sciegen Pharmaceutical Recent Development
11.15 Zydus Pharmaceuticals
11.15.1 Zydus Pharmaceuticals Company Detail
11.15.2 Zydus Pharmaceuticals Business Overview
11.15.3 Zydus Pharmaceuticals Antihistamines Introduction
11.15.4 Zydus Pharmaceuticals Revenue in Antihistamines Business (2018-2023)
11.15.5 Zydus Pharmaceuticals Recent Development
11.16 Alcon Laboratories
11.16.1 Alcon Laboratories Company Detail
11.16.2 Alcon Laboratories Business Overview
11.16.3 Alcon Laboratories Antihistamines Introduction
11.16.4 Alcon Laboratories Revenue in Antihistamines Business (2018-2023)
11.16.5 Alcon Laboratories Recent Development
11.17 Breckenridge Pharmaceutical
11.17.1 Breckenridge Pharmaceutical Company Detail
11.17.2 Breckenridge Pharmaceutical Business Overview
11.17.3 Breckenridge Pharmaceutical Antihistamines Introduction
11.17.4 Breckenridge Pharmaceutical Revenue in Antihistamines Business (2018-2023)
11.17.5 Breckenridge Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Antihistamines Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of 10 mg
Table 3. Key Players of 20 mg
Table 4. Key Players of 30 mg
Table 5. Key Players of Others
Table 6. Global Antihistamines Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 7. Global Antihistamines Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 8. Global Antihistamines Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Antihistamines Market Share by Region (2018-2023)
Table 10. Global Antihistamines Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 11. Global Antihistamines Market Share by Region (2024-2034)
Table 12. Antihistamines Market Trends
Table 13. Antihistamines Market Drivers
Table 14. Antihistamines Market Challenges
Table 15. Antihistamines Market Restraints
Table 16. Global Antihistamines Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Antihistamines Market Share by Players (2018-2023)
Table 18. Global Top Antihistamines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antihistamines as of 2024)
Table 19. Ranking of Global Top Antihistamines Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Antihistamines Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Antihistamines Product Solution and Service
Table 23. Date of Enter into Antihistamines Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Antihistamines Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Antihistamines Revenue Market Share by Type (2018-2023)
Table 27. Global Antihistamines Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 28. Global Antihistamines Revenue Market Share by Type (2024-2034)
Table 29. Global Antihistamines Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Antihistamines Revenue Market Share by Application (2018-2023)
Table 31. Global Antihistamines Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 32. Global Antihistamines Revenue Market Share by Application (2024-2034)
Table 33. North America Antihistamines Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 34. North America Antihistamines Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Antihistamines Market Size by Country (2024-2034) & (US$ Million)
Table 36. Europe Antihistamines Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 37. Europe Antihistamines Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Antihistamines Market Size by Country (2024-2034) & (US$ Million)
Table 39. Asia-Pacific Antihistamines Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 40. Asia-Pacific Antihistamines Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Antihistamines Market Size by Region (2024-2034) & (US$ Million)
Table 42. Latin America Antihistamines Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. Latin America Antihistamines Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Antihistamines Market Size by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Antihistamines Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 46. Middle East & Africa Antihistamines Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Antihistamines Market Size by Country (2024-2034) & (US$ Million)
Table 48. Merck Company Detail
Table 49. Merck Business Overview
Table 50. Merck Antihistamines Product
Table 51. Merck Revenue in Antihistamines Business (2018-2023) & (US$ Million)
Table 52. Merck Recent Development
Table 53. Viatris Company Detail
Table 54. Viatris Business Overview
Table 55. Viatris Antihistamines Product
Table 56. Viatris Revenue in Antihistamines Business (2018-2023) & (US$ Million)
Table 57. Viatris Recent Development
Table 58. Organon Company Detail
Table 59. Organon Business Overview
Table 60. Organon Antihistamines Product
Table 61. Organon Revenue in Antihistamines Business (2018-2023) & (US$ Million)
Table 62. Organon Recent Development
Table 63. Sun Pharmaceutical Industries Company Detail
Table 64. Sun Pharmaceutical Industries Business Overview
Table 65. Sun Pharmaceutical Industries Antihistamines Product
Table 66. Sun Pharmaceutical Industries Revenue in Antihistamines Business (2018-2023) & (US$ Million)
Table 67. Sun Pharmaceutical Industries Recent Development
Table 68. Cardinal Health Company Detail
Table 69. Cardinal Health Business Overview
Table 70. Cardinal Health Antihistamines Product
Table 71. Cardinal Health Revenue in Antihistamines Business (2018-2023) & (US$ Million)
Table 72. Cardinal Health Recent Development
Table 73. Fresenius Kabi Company Detail
Table 74. Fresenius Kabi Business Overview
Table 75. Fresenius Kabi Antihistamines Product
Table 76. Fresenius Kabi Revenue in Antihistamines Business (2018-2023) & (US$ Million)
Table 77. Fresenius Kabi Recent Development
Table 78. Hikma Pharmaceutical Company Detail
Table 79. Hikma Pharmaceutical Business Overview
Table 80. Hikma Pharmaceutical Antihistamines Product
Table 81. Hikma Pharmaceutical Revenue in Antihistamines Business (2018-2023) & (US$ Million)
Table 82. Hikma Pharmaceutical Recent Development
Table 83. Meda Pharmaceuticals Company Detail
Table 84. Meda Pharmaceuticals Business Overview
Table 85. Meda Pharmaceuticals Antihistamines Product
Table 86. Meda Pharmaceuticals Revenue in Antihistamines Business (2018-2023) & (US$ Million)
Table 87. Meda Pharmaceuticals Recent Development
Table 88. Armas Pharmaceuticals Company Detail
Table 89. Armas Pharmaceuticals Business Overview
Table 90. Armas Pharmaceuticals Antihistamines Product
Table 91. Armas Pharmaceuticals Revenue in Antihistamines Business (2018-2023) & (US$ Million)
Table 92. Armas Pharmaceuticals Recent Development
Table 93. Strides Pharma Company Detail
Table 94. Strides Pharma Business Overview
Table 95. Strides Pharma Antihistamines Product
Table 96. Strides Pharma Revenue in Antihistamines Business (2018-2023) & (US$ Million)
Table 97. Strides Pharma Recent Development
Table 98. Aurobindo Pharma Company Detail
Table 99. Aurobindo Pharma Business Overview
Table 100. Aurobindo Pharma Antihistamines Product
Table 101. Aurobindo Pharma Revenue in Antihistamines Business (2018-2023) & (US$ Million)
Table 102. Aurobindo Pharma Recent Development
Table 103. Perrigo Pharmaceuticals Company Detail
Table 104. Perrigo Pharmaceuticals Business Overview
Table 105. Perrigo Pharmaceuticals Antihistamines Product
Table 106. Perrigo Pharmaceuticals Revenue in Antihistamines Business (2018-2023) & (US$ Million)
Table 107. Perrigo Pharmaceuticals Recent Development
Table 108. Micro Labs USA Company Detail
Table 109. Micro Labs USA Business Overview
Table 110. Micro Labs USA Antihistamines Product
Table 111. Micro Labs USA Revenue in Antihistamines Business (2018-2023) & (US$ Million)
Table 112. Micro Labs USA Recent Development
Table 113. Sciegen Pharmaceutical Company Detail
Table 114. Sciegen Pharmaceutical Business Overview
Table 115. Sciegen Pharmaceutical Antihistamines Product
Table 116. Sciegen Pharmaceutical Revenue in Antihistamines Business (2018-2023) & (US$ Million)
Table 117. Sciegen Pharmaceutical Recent Development
Table 118. Zydus Pharmaceuticals Company Detail
Table 119. Zydus Pharmaceuticals Business Overview
Table 120. Zydus Pharmaceuticals Antihistamines Product
Table 121. Zydus Pharmaceuticals Revenue in Antihistamines Business (2018-2023) & (US$ Million)
Table 122. Zydus Pharmaceuticals Recent Development
Table 123. Alcon Laboratories Company Detail
Table 124. Alcon Laboratories Business Overview
Table 125. Alcon Laboratories Antihistamines Product
Table 126. Alcon Laboratories Revenue in Antihistamines Business (2018-2023) & (US$ Million)
Table 127. Alcon Laboratories Recent Development
Table 128. Breckenridge Pharmaceutical Company Detail
Table 129. Breckenridge Pharmaceutical Business Overview
Table 130. Breckenridge Pharmaceutical Antihistamines Product
Table 131. Breckenridge Pharmaceutical Revenue in Antihistamines Business (2018-2023) & (US$ Million)
Table 132. Breckenridge Pharmaceutical Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antihistamines Market Size Comparison by Type (2023-2034) & (US$ Million)
Figure 2. Global Antihistamines Market Share by Type: 2024 VS 2034
Figure 3. 10 mg Features
Figure 4. 20 mg Features
Figure 5. 30 mg Features
Figure 6. Others Features
Figure 7. Global Antihistamines Market Size Comparison by Application (2023-2034) & (US$ Million)
Figure 8. Global Antihistamines Market Share by Application: 2024 VS 2034
Figure 9. Hospital Case Studies
Figure 10. Clinics Case Studies
Figure 11. Pharmacy Case Studies
Figure 12. Others Case Studies
Figure 13. Antihistamines Report Years Considered
Figure 14. Global Antihistamines Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 15. Global Antihistamines Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 16. Global Antihistamines Market Share by Region: 2024 VS 2034
Figure 17. Global Antihistamines Market Share by Players in 2024
Figure 18. Global Top Antihistamines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antihistamines as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Antihistamines Revenue in 2024
Figure 20. North America Antihistamines Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. North America Antihistamines Market Share by Country (2018-2034)
Figure 22. United States Antihistamines Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Canada Antihistamines Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Europe Antihistamines Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. Europe Antihistamines Market Share by Country (2018-2034)
Figure 26. Germany Antihistamines Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. France Antihistamines Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. U.K. Antihistamines Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Italy Antihistamines Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Russia Antihistamines Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Nordic Countries Antihistamines Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Asia-Pacific Antihistamines Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Asia-Pacific Antihistamines Market Share by Region (2018-2034)
Figure 34. China Antihistamines Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Japan Antihistamines Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. South Korea Antihistamines Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Southeast Asia Antihistamines Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. India Antihistamines Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Australia Antihistamines Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Latin America Antihistamines Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Latin America Antihistamines Market Share by Country (2018-2034)
Figure 42. Mexico Antihistamines Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Brazil Antihistamines Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Middle East & Africa Antihistamines Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Middle East & Africa Antihistamines Market Share by Country (2018-2034)
Figure 46. Turkey Antihistamines Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Saudi Arabia Antihistamines Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 48. Merck Revenue Growth Rate in Antihistamines Business (2018-2023)
Figure 49. Viatris Revenue Growth Rate in Antihistamines Business (2018-2023)
Figure 50. Organon Revenue Growth Rate in Antihistamines Business (2018-2023)
Figure 51. Sun Pharmaceutical Industries Revenue Growth Rate in Antihistamines Business (2018-2023)
Figure 52. Cardinal Health Revenue Growth Rate in Antihistamines Business (2018-2023)
Figure 53. Fresenius Kabi Revenue Growth Rate in Antihistamines Business (2018-2023)
Figure 54. Hikma Pharmaceutical Revenue Growth Rate in Antihistamines Business (2018-2023)
Figure 55. Meda Pharmaceuticals Revenue Growth Rate in Antihistamines Business (2018-2023)
Figure 56. Armas Pharmaceuticals Revenue Growth Rate in Antihistamines Business (2018-2023)
Figure 57. Strides Pharma Revenue Growth Rate in Antihistamines Business (2018-2023)
Figure 58. Aurobindo Pharma Revenue Growth Rate in Antihistamines Business (2018-2023)
Figure 59. Perrigo Pharmaceuticals Revenue Growth Rate in Antihistamines Business (2018-2023)
Figure 60. Micro Labs USA Revenue Growth Rate in Antihistamines Business (2018-2023)
Figure 61. Sciegen Pharmaceutical Revenue Growth Rate in Antihistamines Business (2018-2023)
Figure 62. Zydus Pharmaceuticals Revenue Growth Rate in Antihistamines Business (2018-2023)
Figure 63. Alcon Laboratories Revenue Growth Rate in Antihistamines Business (2018-2023)
Figure 64. Breckenridge Pharmaceutical Revenue Growth Rate in Antihistamines Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed